Is targeted therapy possible for patients with gastric adenocarcinoma?

被引：1
|
作者：
Kaya, Dilsa Mizrak [1 ]
Harada, Kazuto [1 ]
Ajani, Jaffer A. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, 1515 Holcombe Blvd,FC10-3022, Houston, TX 77030 USA
来源：
EXPERT OPINION ON PHARMACOTHERAPY | 2016年 / 17卷 / 18期
关键词：
DOUBLE-BLIND; CANCER;
D O I：
10.1080/14656566.2016.1236917
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：2371 / 2374
页数：4
相关论文
共 50 条
  • [31] Personalised therapy for localised gastric and gastro-oesophageal adenocarcinoma
    Badgwell, Brian
    Blum, Mariela
    Estrella, Jeannelyn
    Ajani, Jaffer
    LANCET ONCOLOGY, 2016, 17 (12) : 1628 - 1629
  • [32] Patterns of Initial Recurrence in Gastric Adenocarcinoma in the Era of Preoperative Therapy
    Ikoma, Naruhiko
    Chen, Hsiang-Chun
    Wang, Xuemei
    Blum, Mariela
    Estrella, Jeannelyn S.
    Fournier, Keith
    Mansfield, Paul
    Ajani, Jaffer
    Badgwell, Brian D.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (09) : 2679 - 2687
  • [33] Salvage systemic therapy for advanced gastric and oesophagogastric junction adenocarcinoma
    Tomita, Yoko
    Moldovan, Max
    Lee, Rachael Chang
    Hsieh, Amy H. C.
    Townsend, Amanda
    Price, Timothy
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (11):
  • [34] Mutational landscape of gastric adenocarcinoma in Chinese: Implications for prognosis and therapy
    Chen, Kexin
    Yang, Da
    Li, Xiangchun
    Sun, Baocun
    Song, Fengju
    Cao, Wenfeng
    Brat, Daniel J.
    Gao, Zhibo
    Li, Haixin
    Liang, Han
    Zhao, Yanrui
    Zheng, Hong
    Li, Miao
    Buckner, Jan
    Patterson, Scott D.
    Ye, Xiang
    Reinhard, Christoph
    Bhathena, Anahita
    Joshi, Deepa
    Mischel, Paul S.
    Croce, Carlo M.
    Wang, Yi Michael
    Raghavakaimal, Sreekumar
    Li, Hui
    Lu, Xin
    Pan, Yang
    Chang, Han
    Ba, Sujuan
    Luo, Longhai
    Cavenee, Webster K.
    Zhang, Wei
    Hao, Xishan
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (04) : 1107 - 1112
  • [35] FGA isoform as an indicator of targeted therapy for EGFR mutated lung adenocarcinoma
    Shang, Zhi
    Niu, Xiaomin
    Zhang, Kewei
    Qiao, Zhi
    Liu, Sha
    Jiang, Xiaoteng
    Cao, Chengxi
    Lu, Shun
    Xiao, Hua
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2019, 97 (12): : 1657 - 1668
  • [36] Gastric cancer; actualities and perspectives of early diagnosis and targeted therapy
    Silaghi, Adrian
    Rebegea, Laura Florentina
    Balan, Daniela Gabriela
    Dumitriu, Anca
    Paunica, Stana
    Balalau, Cristian
    Cojan, Stefanita Tenea
    Epistatu, Dragos
    Constantin, Vlad Denis
    JOURNAL OF MIND AND MEDICAL SCIENCES, 2023, 10 (02): : 196 - 208
  • [37] Targeted therapy for gastric cancer: Molecular pathways and ongoing investigations
    Yang, Wei
    Raufi, Alexander
    Klempner, Samuel J.
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2014, 1846 (01): : 232 - 237
  • [38] Targeted therapy for gastric cancer: Current status and future directions
    Yuan, Dan-Dan
    Zhu, Zhong-Xiu
    Zhang, Xia
    Liu, Jie
    ONCOLOGY REPORTS, 2016, 35 (03) : 1245 - 1254
  • [39] The Clinicopathological Characteristics and Prognoses of dMMR Gastric Adenocarcinoma Patients
    Wang, Jie
    Xi, Yanfeng
    Zhao, Jian
    Rong, Xuetong
    Lu, Weidong
    Wang, Yusheng
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2021, 2021
  • [40] Factors That Affect Life Expectancy of Patients With Gastric Adenocarcinoma
    Chen, Wei-Ying
    Cheng, Hsiu-Chi
    Wang, Jung-Der
    Sheu, Bor-Shyang
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (12) : 1595 - 1600
12345